AR102420A1 - Sitios de integración en celulas cho y sus usos - Google Patents
Sitios de integración en celulas cho y sus usosInfo
- Publication number
- AR102420A1 AR102420A1 ARP150103445A ARP150103445A AR102420A1 AR 102420 A1 AR102420 A1 AR 102420A1 AR P150103445 A ARP150103445 A AR P150103445A AR P150103445 A ARP150103445 A AR P150103445A AR 102420 A1 AR102420 A1 AR 102420A1
- Authority
- AR
- Argentina
- Prior art keywords
- expression
- integration sites
- cho cells
- eukaryotic
- improved
- Prior art date
Links
- 230000010354 integration Effects 0.000 title abstract 2
- 230000014509 gene expression Effects 0.000 abstract 4
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000010473 stable expression Effects 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 230000002759 chromosomal effect Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462067774P | 2014-10-23 | 2014-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR102420A1 true AR102420A1 (es) | 2017-03-01 |
Family
ID=54602002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150103445A AR102420A1 (es) | 2014-10-23 | 2015-10-23 | Sitios de integración en celulas cho y sus usos |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US9816110B2 (enExample) |
| EP (1) | EP3209785B1 (enExample) |
| JP (1) | JP6668340B2 (enExample) |
| KR (1) | KR102243243B1 (enExample) |
| CN (1) | CN107109434A (enExample) |
| AR (1) | AR102420A1 (enExample) |
| AU (1) | AU2015335921B2 (enExample) |
| BR (1) | BR112017008022A2 (enExample) |
| CA (1) | CA2965495C (enExample) |
| EA (1) | EA037255B1 (enExample) |
| IL (1) | IL251674B (enExample) |
| MX (1) | MX2017005306A (enExample) |
| MY (1) | MY184103A (enExample) |
| SG (1) | SG11201703149RA (enExample) |
| TW (2) | TWI747808B (enExample) |
| WO (1) | WO2016064999A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3209785B1 (en) | 2014-10-23 | 2019-07-31 | Regeneron Pharmaceuticals, Inc. | Novel cho integration sites and uses thereof |
| US10329594B1 (en) | 2015-09-03 | 2019-06-25 | CHO Plus, Inc. | Cell lines for high level production of protein-based pharmaceuticals |
| US11649449B2 (en) | 2015-09-03 | 2023-05-16 | CHO Plus, Inc. | Hybrid cell lines for high level production of a target protein |
| US11512144B2 (en) | 2016-04-20 | 2022-11-29 | Regeneran Pharmaceuticals, Inc. | Compositions and methods for making antibodies based on use of an expression-enhancing loci |
| IL262268B2 (en) * | 2016-04-20 | 2024-05-01 | Regeneron Pharma | Compositions and methods for making antibodies based on use of an expression-enhancing locus |
| WO2018039499A1 (en) | 2016-08-24 | 2018-03-01 | Regeneron Pharmaceuticals, Inc. | Host cell protein modification |
| EP3559236A4 (en) * | 2016-12-20 | 2020-11-04 | Development Center for Biotechnology | TARGETED INTEGRATION SITES IN THE CHINESE HAMSTER OVARIAN CELL GENOME |
| US20210309988A1 (en) * | 2017-02-07 | 2021-10-07 | Sigma-Aldrich Co. Llc | Stable targeted integration |
| EP3583205A1 (en) * | 2017-02-17 | 2019-12-25 | Lonza Ltd | Mammalian cells for producing adeno-associated viruses |
| EP3601542A4 (en) * | 2017-03-19 | 2021-01-13 | Applied Stemcell, Inc. | NEW INTEGRATION SITES AND THEIR USES |
| JP7087061B2 (ja) * | 2017-08-11 | 2022-06-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｈｏ細胞内の組込み部位 |
| CN107723276B (zh) * | 2017-11-02 | 2021-08-13 | 上海交通大学 | 一种稳定高表达目标产物的细胞株的构建方法和试剂盒 |
| CN111566208A (zh) * | 2017-12-22 | 2020-08-21 | 生物辐射实验室股份有限公司 | 利用CRISPR/Cas基因靶向控制生物体表型 |
| TW201932600A (zh) * | 2017-12-22 | 2019-08-16 | 美商建南德克公司 | 核酸之靶向整合 |
| CN109321604B (zh) * | 2018-10-30 | 2021-07-06 | 江南大学 | 一种cho细胞基因组内nw_006882077-1稳定表达蛋白质的应用 |
| CN109337927B (zh) * | 2018-10-30 | 2021-07-06 | 江南大学 | 一种cho细胞基因组内nw_006880285-1稳定表达蛋白质的应用 |
| CN109295092B (zh) * | 2018-10-30 | 2021-06-29 | 江南大学 | 一种cho细胞基因组内nw_003613638-1稳定表达蛋白质的应用 |
| CN109295093B (zh) * | 2018-10-30 | 2021-08-03 | 江南大学 | 一种cho细胞基因组内nw_006882456-1稳定表达蛋白质的应用 |
| CN109207432B (zh) * | 2018-10-30 | 2021-08-03 | 江南大学 | 一种cho细胞基因组内nw_006883358-1稳定表达蛋白质的应用 |
| CN109136193B (zh) * | 2018-10-30 | 2021-07-06 | 江南大学 | 一种cho细胞基因组内nw_006884764-1稳定表达蛋白质的应用 |
| KR20210107057A (ko) * | 2018-12-21 | 2021-08-31 | 제넨테크, 인크. | 핵산의 표적화 통합 |
| IL286630B2 (en) * | 2019-04-02 | 2025-05-01 | Chugai Pharmaceutical Co Ltd | Method for introducing a target-specific foreign gene |
| CN114080454A (zh) | 2019-06-26 | 2022-02-22 | 豪夫迈·罗氏有限公司 | 核酸的随机化构型靶向整合 |
| EP3901266A1 (en) * | 2020-04-22 | 2021-10-27 | LEK Pharmaceuticals d.d. | Super-enhancers for recombinant gene expression in cho cells |
| EP4158041A4 (en) * | 2020-06-02 | 2024-09-25 | Catalent Pharma Solutions, LLC | CELL LINES WITH MULTIPLE DOCKING ZONES FOR GENE INSERTION |
| TW202216991A (zh) * | 2020-06-24 | 2022-05-01 | 美商建南德克公司 | 核酸之靶向整合 |
| IL302046A (en) | 2020-10-15 | 2023-06-01 | Hoffmann La Roche | Nucleic acid structures for va RNA transcription |
| CN113755447B (zh) * | 2021-09-23 | 2022-04-29 | 云舟生物科技(广州)股份有限公司 | 一种用于生产腺病毒的293a细胞株及其制备与应用 |
| KR20240099242A (ko) | 2021-10-18 | 2024-06-28 | 리제너론 파마슈티칼스 인코포레이티드 | 안정적인 통합 부위를 생산하기 위한 통합된 cas9 유전자를 포함하는 포유동물 세포, 및 안정적인 통합 부위 및 기타 부위를 포함하는 포유동물 세포 |
| MX2024004647A (es) | 2021-10-18 | 2024-05-02 | Regeneron Pharma | Celulas eucariotas que comprenden polinucleotidos de virus asociados a adenovirus. |
| KR20240101596A (ko) | 2021-10-18 | 2024-07-02 | 리제너론 파마슈티칼스 인코포레이티드 | 폴리뉴클레오티드의 제어된 전사 |
| WO2023147462A2 (en) * | 2022-01-28 | 2023-08-03 | The Trustees Of Columbia University In The City Of New York | Genetic modifications for xenotransplantation |
| CN117305334B (zh) * | 2022-06-21 | 2024-11-08 | 深圳太力生物技术有限责任公司 | 靶向整合细胞及其制备方法、生产目标基因表达产物的方法 |
| WO2024107451A1 (en) | 2022-11-18 | 2024-05-23 | Regeneron Pharmaceuticals, Inc. | Methods for detecting and evaluating viruses and virus-like particles |
| CN118726475B (zh) * | 2023-03-28 | 2025-07-08 | 深圳太力生物技术有限责任公司 | 核酸、重组载体、靶向整合细胞、基因表达方法和应用 |
| WO2024211287A1 (en) * | 2023-04-03 | 2024-10-10 | Seagen Inc. | Production cell lines with targeted integration sites |
| TW202528546A (zh) | 2023-09-07 | 2025-07-16 | 美商再生元醫藥公司 | 經共價表面修飾之腺相關病毒的生產及純化 |
| WO2025111473A1 (en) | 2023-11-21 | 2025-05-30 | Regeneron Pharmaceuticals, Inc. | Covalently surface modified adeno-associated virus production by in vitro conjugation, and purification of covalently surface modified adeno-associated virus |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
| ATE539161T1 (de) | 1998-07-21 | 2012-01-15 | Millipore Corp | Ein ein allgegenwärtiges chromatin-öffnendes element (ucoe) enthaltendes polynucleotid |
| US6521419B1 (en) * | 1998-09-22 | 2003-02-18 | Kanakaraju Koduri | Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| AU2002254529A1 (en) | 2001-04-04 | 2002-10-21 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of | Nucleic acids for transgene expression |
| US20040045043A1 (en) * | 2002-05-20 | 2004-03-04 | Finney Robert E. | Compositions and methods for generating conditional knockouts |
| US8673589B2 (en) | 2002-05-29 | 2014-03-18 | Regeneron Pharmaceuticals, Inc. | Inducible eukaryotic expression system |
| EP2150617B1 (en) | 2007-06-04 | 2014-10-22 | Regeneron Pharmaceuticals, Inc. | Enhanced expression and stability regions |
| ES2627552T3 (es) * | 2008-12-04 | 2017-07-28 | Sigma Aldrich Company | Edición de genoma en ratas usando nucleasas con dedos de cinc |
| CN105969807A (zh) * | 2011-04-05 | 2016-09-28 | 斯克利普斯研究所 | 染色体着陆垫及相关用途 |
| EP3403672A1 (en) | 2011-04-20 | 2018-11-21 | Medlmmune, LLC | Antibodies and other molecules that bind b7-h1 and pd-1 |
| EP3683319A1 (en) * | 2011-06-01 | 2020-07-22 | Precision Biosciences, Inc. | Methods and products for producing engineered mammalian cell lines with amplified transgenes |
| CA2852955C (en) * | 2011-10-27 | 2021-02-16 | Sangamo Biosciences, Inc. | Methods and compositions for modification of the hprt locus |
| CA2871524C (en) | 2012-05-07 | 2021-07-27 | Sangamo Biosciences, Inc. | Methods and compositions for nuclease-mediated targeted integration of transgenes |
| EP3209785B1 (en) | 2014-10-23 | 2019-07-31 | Regeneron Pharmaceuticals, Inc. | Novel cho integration sites and uses thereof |
-
2015
- 2015-10-21 EP EP15797495.7A patent/EP3209785B1/en active Active
- 2015-10-21 EA EA201790698A patent/EA037255B1/ru unknown
- 2015-10-21 WO PCT/US2015/056653 patent/WO2016064999A1/en not_active Ceased
- 2015-10-21 CN CN201580069889.1A patent/CN107109434A/zh active Pending
- 2015-10-21 JP JP2017519646A patent/JP6668340B2/ja active Active
- 2015-10-21 BR BR112017008022-2A patent/BR112017008022A2/pt not_active Application Discontinuation
- 2015-10-21 MY MYPI2017701254A patent/MY184103A/en unknown
- 2015-10-21 CA CA2965495A patent/CA2965495C/en active Active
- 2015-10-21 SG SG11201703149RA patent/SG11201703149RA/en unknown
- 2015-10-21 US US14/919,300 patent/US9816110B2/en active Active
- 2015-10-21 AU AU2015335921A patent/AU2015335921B2/en active Active
- 2015-10-21 KR KR1020177012465A patent/KR102243243B1/ko active Active
- 2015-10-21 MX MX2017005306A patent/MX2017005306A/es unknown
- 2015-10-22 TW TW104134716A patent/TWI747808B/zh active
- 2015-10-22 TW TW110128495A patent/TWI780847B/zh active
- 2015-10-23 AR ARP150103445A patent/AR102420A1/es unknown
-
2017
- 2017-04-09 IL IL251674A patent/IL251674B/en active IP Right Grant
- 2017-10-13 US US15/783,525 patent/US20180030480A1/en not_active Abandoned
-
2019
- 2019-09-19 US US16/575,506 patent/US11788102B2/en active Active
-
2021
- 2021-02-12 US US17/175,025 patent/US11268109B2/en active Active
-
2023
- 2023-09-06 US US18/461,798 patent/US20240018553A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170096999A (ko) | 2017-08-25 |
| KR102243243B1 (ko) | 2021-04-22 |
| TWI747808B (zh) | 2021-12-01 |
| EP3209785B1 (en) | 2019-07-31 |
| EP3209785A1 (en) | 2017-08-30 |
| AU2015335921A1 (en) | 2017-05-04 |
| TW202144576A (zh) | 2021-12-01 |
| SG11201703149RA (en) | 2018-02-27 |
| JP6668340B2 (ja) | 2020-03-18 |
| CA2965495C (en) | 2022-05-24 |
| US20160115502A1 (en) | 2016-04-28 |
| MY184103A (en) | 2021-03-18 |
| US11268109B2 (en) | 2022-03-08 |
| CA2965495A1 (en) | 2016-04-28 |
| US20180030480A1 (en) | 2018-02-01 |
| EA037255B1 (ru) | 2021-02-26 |
| US20210171984A1 (en) | 2021-06-10 |
| US20240018553A1 (en) | 2024-01-18 |
| CN107109434A (zh) | 2017-08-29 |
| US9816110B2 (en) | 2017-11-14 |
| TW201629229A (zh) | 2016-08-16 |
| WO2016064999A1 (en) | 2016-04-28 |
| IL251674A0 (en) | 2017-06-29 |
| AU2015335921B2 (en) | 2020-06-25 |
| EA201790698A1 (ru) | 2018-01-31 |
| MX2017005306A (es) | 2018-01-09 |
| TWI780847B (zh) | 2022-10-11 |
| US20200002732A1 (en) | 2020-01-02 |
| JP2017535258A (ja) | 2017-11-30 |
| BR112017008022A2 (pt) | 2018-02-20 |
| IL251674B (en) | 2020-10-29 |
| US11788102B2 (en) | 2023-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR102420A1 (es) | Sitios de integración en celulas cho y sus usos | |
| MX2020004541A (es) | Edicion de genes de celulas primarias. | |
| CO2019013609A2 (es) | Vectores de neoantígeno de alfavirus | |
| MX388517B (es) | Polipéptidos de transposasa y sus usos. | |
| CY1123823T1 (el) | Βελτιωμενες συνθεσεις τ κυτταρων | |
| CO2019006541A2 (es) | Administración viral de neoantígenos | |
| MX2018007519A (es) | Alteracion dirigida del receptor celular del complejo mayor de histocompatibilidad (mhc). | |
| SA518400623B1 (ar) | جينات ديستروفين صغير محسنة ومجموعات إظهارها واستخدامها | |
| CO2017011957A2 (es) | Variantes de alfa-amilasa y polinucleótidos que codifican las mismas | |
| BR112016025519A2 (pt) | engenharia genética in vivo com vetores de adenovírus | |
| CL2018002723A1 (es) | Electrolito para célula electroquímica recargable | |
| MX2019012311A (es) | Metodos y composiciones para modificaciones geneticas dirigidas y metodos de uso. | |
| BR112018005937A2 (pt) | conjugados de oligonucleotídeo de afinidade e usos destes | |
| EA201992795A1 (ru) | Способ получения эукариотических клеток с отредактированной днк и набор, используемый в этом способе | |
| GB201609811D0 (en) | Methods, cells, systems, arrays, RNA and kits | |
| MX388784B (es) | Métodos y composiciones para la modificación genética dirigida a través de direccionamiento múltiple de una sola etapa. | |
| MX382223B (es) | Regulacion de expresion genica mediada por nucleasa. | |
| AR103225A1 (es) | Composiciones detergentes, variantes de lipasa y polinucleótidos que las codifican | |
| BR112015030972A8 (pt) | células sc-beta e composições e métodos para geração das mesmas | |
| MX2017009506A (es) | Polinucleotidos de acido desoxirribonucleico (adn)/acido ribonucleico (arn) hibridos de repeticiones palindromicas cortas agrupadas regularmente separadas (crispr) y sus metodos de uso. | |
| MX2017007127A (es) | Composiciones que comprenden polipeptidos que tienen actividad xilanasa y polipeptidos que tienen actividad arabinofuranosidasa. | |
| MX380562B (es) | Modificaciones de sistemas, métodos y composiciones guía optimizadas para la manipulación de secuencias. | |
| PE20150336A1 (es) | Metodos y composiciones para la modificacion de adn objetivo dirigida por arn y para la modulacion de la transcripcion dirigida por arn | |
| MY181693A (en) | Dual quencher probes | |
| BR112017017886A2 (pt) | gerando populações de células endoteliais arteriais |